Curis, Inc. (CRIS) Financials

CRIS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 77.3 million 57.6 million
2023-09-30 90.0 million 60.4 million
2023-06-30 84.3 million 58.1 million
2023-03-31 94.5 million 58.0 million

CRIS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -10.2 million 1.5 million
2023-09-30 -8.2 million 1.6 million
2023-06-30 -7.9 million 1.4 million
2023-03-31 -12.2 million 1.4 million

CRIS Net Income

No data available :(

CRIS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 56.3 million - 2.8 million
2023-09-30 68.5 million - 3.1 million
2023-06-30 63.5 million - 3.4 million
2023-03-31 71.8 million - 3.7 million

CRIS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 5.8 million
2023-09-30 5.7 million
2023-06-30 4.8 million
2023-03-31 4.8 million

CRIS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 10.0 million 4.9 million -
2023-09-30 - 10.4 million 4.8 million -
2023-06-30 - 10.0 million 4.2 million -
2023-03-31 - 9.1 million 4.8 million -

CRIS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.7 million 158000
2023-09-30 2.8 million 60000
2023-06-30 2.2 million 74000
2023-03-31 2.3 million 24000

CRIS

Price: $16.10

52 week price:
0.38
19.60

Earnings Per Share: -8.96 USD

P/E Ratio: -0.91

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 479800

Ebitda: -14.2 million

Market Capitalization: 96.4 million

Links: